Department of Cardiology, Med. Univ. of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):375-382. doi: 10.1093/ehjci/jeaa341.
As advances in oncology therapies lead to significant improvement in life expectancy of many cancer entities, short-, and long-term cardiac side effects of oncology treatments gain increasing importance. In search of new screening modalities, echocardiography currently presents the best established and clinically easily feasible tool to detect cardiotoxicity in patients undergoing cancer therapy. This review focusses on the most commonly used oncology therapies and aims to give a practical approach to guide clinicians caring for this growing number of patients.
随着肿瘤学治疗方法的进步，许多癌症实体的预期寿命得到了显著延长，肿瘤治疗的短期和长期心脏副作用也变得越来越重要。为了寻找新的筛查方式，超声心动图目前是检测接受癌症治疗的患者发生心脏毒性的最佳且临床易于实施的工具。本文重点介绍了最常用的肿瘤学治疗方法，并旨在为治疗这类患者人数不断增加的临床医生提供实用的指导方法。
